Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer
出版年份 2020 全文链接
标题
Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer
作者
关键词
-
出版物
Science Advances
Volume 6, Issue 3, Pages eaax3931
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2020-01-16
DOI
10.1126/sciadv.aax3931
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Leveraging Surface Plasmon Resonance to Dissect the Interfacial Properties of Nanoparticles: Implications for Tissue Binding and Tumor Penetration
- (2019) Aniket S. Wadajkar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
- (2018) Alice Lee et al. CANCER TREATMENT REVIEWS
- Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
- (2018) Sheheryar Kabraji et al. CLINICAL CANCER RESEARCH
- Focus on Fundamentals: Achieving Effective Nanoparticle Targeting
- (2018) Gregory T. Tietjen et al. TRENDS IN MOLECULAR MEDICINE
- Protein corona: a new approach for nanomedicine design
- (2017) Van Hong Nguyen et al. International Journal of Nanomedicine
- Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas
- (2017) Aniket S. Wadajkar et al. JOURNAL OF CONTROLLED RELEASE
- Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer
- (2017) Chunsheng He et al. JOURNAL OF CONTROLLED RELEASE
- Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy
- (2017) Yu-Cheng Su et al. Nature Communications
- Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis
- (2017) Antonio Martínez-Aranda et al. Frontiers in Oncology
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Non-specific binding and steric hindrance thresholds for penetration of particulate drug carriers within tumor tissue
- (2016) Jimena G. Dancy et al. JOURNAL OF CONTROLLED RELEASE
- Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy
- (2015) Rammohan Devulapally et al. ACS Nano
- Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells
- (2015) Craig S. Schneider et al. BIOMATERIALS
- Emerging Strategies for Treating Brain Metastases from Breast Cancer
- (2015) David P. Kodack et al. CANCER CELL
- Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle
- (2015) E. C. Dreaden et al. CLINICAL CANCER RESEARCH
- Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics
- (2015) Craig S. Schneider et al. JOURNAL OF CONTROLLED RELEASE
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics
- (2015) J G Perez et al. ONCOGENE
- A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models
- (2015) Jayanta Bhattacharyya et al. Nature Communications
- Albumin-bound paclitaxel in solid tumors: clinical development and future directions
- (2015) Madappa Kundranda et al. Drug Design Development and Therapy
- Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells
- (2015) Hsueh-Te Lee et al. Oncotarget
- Ex vivo Evans blue assessment of the blood brain barrier in three breast cancer brain metastasis models
- (2014) John Do et al. BREAST CANCER RESEARCH AND TREATMENT
- Regulation of Fibroblast Growth Factor-inducible 14 (Fn14) Expression Levels via Ligand-independent Lysosomal Degradation
- (2014) Sujatha Gurunathan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of Human Serine Protease-Based Therapeutics Targeting Fn14 and Identification of Fn14 as a New Target Overexpressed in TNBC
- (2014) H. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts
- (2014) Ludmilla de Plater et al. PLoS One
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeted Therapy for Breast Cancer
- (2013) Ali Mohamed et al. AMERICAN JOURNAL OF PATHOLOGY
- nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis
- (2013) Joyce O’Shaughnessy et al. BREAST CANCER RESEARCH AND TREATMENT
- Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors
- (2013) H. Zhou et al. CANCER RESEARCH
- Paclitaxel-loaded PCL–TPGS nanoparticles: In vitro and in vivo performance compared with Abraxane®
- (2013) Ezequiel Bernabeu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies
- (2013) Valentina Guarneri et al. DRUGS
- Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
- (2013) Anna Salvati et al. Nature Nanotechnology
- Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
- (2013) Carey K. Anders et al. PLoS One
- TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic
- (2013) Emily Cheng et al. Frontiers in Immunology
- Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb
- (2012) Debra T. Chao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment
- (2012) Hong Zhou et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Expression of Endoplasmic Reticulum Stress Proteins Is a Candidate Marker of Brain Metastasis in both ErbB-2+ and ErbB-2− Primary Breast Tumors
- (2011) Rebeca Sanz-Pamplona et al. AMERICAN JOURNAL OF PATHOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Targeting of drugs and nanoparticles to tumors
- (2010) Erkki Ruoslahti et al. JOURNAL OF CELL BIOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
- (2009) Kazuki N. Sugahara et al. CANCER CELL
- Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
- (2009) Farrah Kassam et al. Clinical Breast Cancer
- Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts
- (2009) A. Baschnagel et al. MOLECULAR CANCER THERAPEUTICS
- Pattern of metastatic spread in triple-negative breast cancer
- (2008) Rebecca Dent et al. BREAST CANCER RESEARCH AND TREATMENT
- The Fibroblast Growth Factor-Inducible 14 Receptor Is Highly Expressed in HER2-Positive Breast Tumors and Regulates Breast Cancer Cell Invasive Capacity
- (2008) A. L. Willis et al. MOLECULAR CANCER RESEARCH
- Targeting of albumin-embedded paclitaxel nanoparticles to tumors
- (2008) Priya Prakash Karmali et al. Nanomedicine-Nanotechnology Biology and Medicine
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
- (2008) Jeffrey A. Winkles NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now